Ohta T - Search Results

1

Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas.

Ohta T, Watanabe T, Katayama Y, Yoshino A, Yachi K, Ogino A, Komine C, Fukushima T. Ohta T, et al. Oncol Rep. 2006 Nov;16(5):957-63. Oncol Rep. 2006. PMID: 17016577

2

Gene expression profiling predicts response to temozolomide in malignant gliomas.

Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E, Tsumoto K. Yoshino A, et al. Among authors: ohta t. Int J Oncol. 2010 Jun;36(6):1367-77. doi: 10.3892/ijo_00000621. Int J Oncol. 2010. PMID: 20428759

3

Aberrant hypermethylation of non-promoter zygote arrest 1 (ZAR1) in human brain tumors.

Watanabe T, Yachi K, Ohta T, Fukushima T, Yoshino A, Katayama Y, Shinojima Y, Terui T, Nagase H. Watanabe T, et al. Among authors: ohta t. Neurol Med Chir (Tokyo). 2010;50(12):1062-9. doi: 10.2176/nmc.50.1062. Neurol Med Chir (Tokyo). 2010. PMID: 21206179 Free article.

4

Efficacy of ribavirin against malignant glioma cell lines: Follow-up study.

Ochiai Y, Sano E, Okamoto Y, Yoshimura S, Makita K, Yamamuro S, Ohta T, Ogino A, Tadakuma H, Ueda T, Nakayama T, Hara H, Yoshino A, Katayama Y. Ochiai Y, et al. Among authors: ohta t. Oncol Rep. 2018 Feb;39(2):537-544. doi: 10.3892/or.2017.6149. Epub 2017 Dec 11. Oncol Rep. 2018. PMID: 29251333 Free PMC article.

5

O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course.

Watanabe T, Katayama Y, Komine C, Yoshino A, Ogino A, Ohta T, Fukushima T. Watanabe T, et al. Among authors: ohta t. Int J Cancer. 2005 Feb 10;113(4):581-7. doi: 10.1002/ijc.20625. Int J Cancer. 2005. PMID: 15455376

6

Promoter hypermethylation of mismatch repair gene hMLH1 predicts the clinical response of malignant astrocytomas to nitrosourea.

Fukushima T, Katayama Y, Watanabe T, Yoshino A, Ogino A, Ohta T, Komine C. Fukushima T, et al. Among authors: ohta t. Clin Cancer Res. 2005 Feb 15;11(4):1539-44. doi: 10.1158/1078-0432.CCR-04-1625. Clin Cancer Res. 2005. PMID: 15746058

7

Preliminary individualized chemotherapy for malignant astrocytomas based on O6-methylguanine-deoxyribonucleic acid methyltransferase methylation analysis.

Watanabe T, Katayama Y, Ogino A, Ohta T, Yoshino A, Fukushima T. Watanabe T, et al. Among authors: ohta t. Neurol Med Chir (Tokyo). 2006 Aug;46(8):387-93; discussion 393-4. doi: 10.2176/nmc.46.387. Neurol Med Chir (Tokyo). 2006. PMID: 16936459 Free article.

8

Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.

Yoshino A, Katayama Y, Ogino A, Watanabe T, Yachi K, Ohta T, Komine C, Yokoyama T, Fukushima T. Yoshino A, et al. Among authors: ohta t. J Neurooncol. 2007 Jun;83(2):153-62. doi: 10.1007/s11060-006-9316-9. Epub 2007 Jan 11. J Neurooncol. 2007. PMID: 17216555

9

Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression.

Watanabe T, Katayama Y, Yoshino A, Yachi K, Ohta T, Ogino A, Komine C, Fukushima T. Watanabe T, et al. Among authors: ohta t. Brain Pathol. 2007 Jan;17(1):5-10. doi: 10.1111/j.1750-3639.2006.00030.x. Brain Pathol. 2007. PMID: 17493032 Free PMC article.

10

Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.

Yachi K, Watanabe T, Ohta T, Fukushima T, Yoshino A, Ogino A, Katayama Y, Nagase H. Yachi K, et al. Among authors: ohta t. Int J Oncol. 2008 Sep;33(3):469-75. Int J Oncol. 2008. PMID: 18695875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,626 results

Search Page

Filters